Lunai Bioworks Inc. (NASDAQ:LNAI) said it has signed a binding agreement to purchase blood-brain barrier delivery technology ...

Shares of Lunai Bioworks Inc. LNAI are soaring Thursday after the company announced that it will acquire blood-brain barrier ...

Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced the initiation of first-in-human (FIH) dosing in a Phase 1 clinical trial ...

AI life sciences stock Lunai Bioworks (NASDAQ: LNAI) surges after $20 million CNS drug delivery acquisition, strengthening ...

Ginkgo Bioworks (NYSE:DNA) used its fourth-quarter earnings call to outline a sharpened strategic focus for 2026 centered on ...

Ginkgo Bioworks is a cell programming specialist that has partnered with many big companies. It is in a very early stage, but has a lot of promising opportunities in the long run. A big part of the ...

Some analysts and portfolio managers see a bright future for Ginkgo Bioworks. Each collaborator that signs on is a vote of confidence in its future success. However, keep in mind that the biofoundry ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here’s a look at what’s going on. What To Know: Ginkgo Bioworks shares appear to be getting ...

I’ve spent a good deal of my career thinking about how we structure and fund research in the biomedical sciences in the U.S. and questioning whether the U.S. model of embedding research in ...